4.5 Article

Association between surveillance imaging and survival outcomes in small bowel neuroendocrine tumors

Journal

JOURNAL OF SURGICAL ONCOLOGY
Volume 127, Issue 4, Pages 578-586

Publisher

WILEY
DOI: 10.1002/jso.27176

Keywords

recurrence; small bowel neuroendocrine tumors; surveillance imaging; survival

Ask authors/readers for more resources

This study evaluated the impact of surveillance imaging on recurrence and overall survival in patients with resected small bowel neuroendocrine tumors (SB-NETs). The results showed that imaging frequency was predictive of recurrence, and patients who received treatment for recurrent disease had comparable overall survival to those who did not recur. Additionally, less frequent imaging over a longer duration was emphasized to capture clinically relevant recurrences that can be treated to improve overall survival.
BackgroundSurveillance guidelines following the resection of small bowel neuroendocrine tumors (SB-NETs) are inconsistent. We evaluated the impact of surveillance imaging on SB-NET recurrence and overall survival (OS). MethodsPatients with completely resected SB-NETs referred to a provincial cancer center (2004-2015) were reviewed. Associations between imaging frequency, recurrence, post-recurrence treatment, and OS were determined using univariate and Cox-regression analyses. ResultsAmong 195 completely resected SB-NET patients, 31% were >= 70 years, 43% were female, and 80% had grade 1 disease. Imaging frequency was predictive of recurrence (hazard ratio 2.52, 95% confidence interval 1.84-3.46, p < 0.001). 72% underwent interventions for recurrent disease. Patients who were treated for the recurrent disease had comparable OS to those who did not recur (median 152 vs. 164 months; p = 0.25). Imaging frequency was not associated with OS in those with treated recurrent disease (p = 0.65). Patients who recurred underwent more computerized tomography (CT) scans than those who did not recur (CT: 1.47 +/- 0.89 vs. 1.02 +/- 0.81 scans/year, p < 0.001). Detection of disease recurrence was 5%-7% per year during the first 6 years of surveillance and peaked at 17% in Year 9. ConclusionLess frequent imaging over a longer duration should be emphasized to capture clinically relevant recurrences that can be treated to improve OS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available